Please ensure Javascript is enabled for purposes of website accessibility
Drugs Fail to Slow Decline in Inherited Alzheimer's Disease
gvw_ap_news
By Associated Press
Published 5 years ago on
February 10, 2020

Share

Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer’s disease at a relatively young age because they inherited rare gene flaws.

“We actually don’t even know yet what the drugs did” in term of removing that protein because those results are still being analyzed, said study leader Dr. Randall Bateman at Washington University in St. Louis, Missouri.
The results announced Monday are another disappointment for the approach that scientists have focused on for years — trying to remove a harmful protein that builds up in the brains of people with Alzheimer’s, the leading cause of dementia.
“We actually don’t even know yet what the drugs did” in term of removing that protein because those results are still being analyzed, said study leader Dr. Randall Bateman at Washington University in St. Louis, Missouri.
But after five years on average, the main goal of the study was not met — people on either of the drugs scored about the same on thinking and memory tests as others given placebo treatments.
More than 5 million people in the United States and millions more worldwide have Alzheimer’s. Current drugs only temporarily ease symptoms and do not alter the course of the disease.

Both Drugs Gave Disappointing Results in Some Earlier Studies

The study tested solanezumab by Eli Lilly & Co., and gantenerumab by Swiss drugmaker Roche and its U.S. subsidiary, Genentech. Both drugs gave disappointing results in some earlier studies, but the doses in this one ranged up to four to five times higher and researchers had hoped that would prove more effective.
The study was funded by the U.S. National Institute on Aging, the Alzheimer’s Association and some foundations.
It involved about 200 people in the United States, Europe and elsewhere with flaws in one of three genes.
“If you get one of these genetic mutations you’re almost guaranteed to get Alzheimer’s,” typically in your 30s, 40s or 50s, said Dr. Eric McDade, another study leader at Washington University.
People like this account for only about 1% of Alzheimer’s cases, but their brain changes and symptoms are similar to those who develop the disease at a later age. That gives a unique chance to test potential treatments.
“We know everyone will get sick and we know about what time that is” in their lives, Bateman said.

Details Will Be Given at a Medical Meeting in April

Most study participants already had signs of the harmful protein in their brain even if they were showing no symptoms when the study started.
The were given either a gantenerumab shot, an IV of solanezumab or fake versions of these treatments every four weeks. The drugs made no difference in a combination score of four memory and thinking tests compared to placebo treatments.

Side effects were not disclosed, but “there’s no evidence of any drug-related deaths in the trial,” McDade said.
Side effects were not disclosed, but “there’s no evidence of any drug-related deaths in the trial,” McDade said.
Details will be given at a medical meeting in April.
Solanezumab is being tested in another study to see if it can slow memory loss in people with Alzheimer’s.
Gantenerumab also is being tested in two other large experiments that are expected to give results in two to three years.
It’s unclear whether the results will affect views on aducanumab, another experimental drug whose makers say it can remove the harmful protein and slow mental decline. Results on it have been mixed, and the companies have said they will seek federal approval for it soon. Cambridge, Massachusetts-based Biogen is developing it with a Japanese company, Eisai Co. Ltd.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

World’s Largest Almond Processor Will Shutter Sacramento Plant. 600 Workers Impacted

DON'T MISS

Trump Eyes Major Funding Cuts for California, Including All Public Universities

DON'T MISS

Farming Regulation Costs Rise 1,300% Since 2006: Cal Poly

DON'T MISS

Southern California Air Regulators Weigh a Plan to Phase Out Gas Furnaces and Water Heaters

DON'T MISS

US Supreme Court Allows DOGE Broad Access to Social Security Data

DON'T MISS

Doctors Were Preparing to Remove Their Organs. Then They Woke Up.

DON'T MISS

Abrego Garcia Is Returned to US From El Salvador

DON'T MISS

Proud Boys Convicted in Jan. 6 Attack Sue Government on Claims of ‘Political Persecution’

DON'T MISS

FDA’s AI Assistant ‘Elsa’ Fails Its First Day on the Job

DON'T MISS

Documentary Series Goes Inside Trump’s Bubble

UP NEXT

FDA’s AI Assistant ‘Elsa’ Fails Its First Day on the Job

UP NEXT

8 Ways Musk and Trump Could Inflict Pain on Each Other

UP NEXT

D-Day Veterans Return to Normandy to Mark 81st Anniversary of Landings

UP NEXT

Lambda Legal, a Nonprofit Supporting LGBTQ+ Rights, Exceeded Fundraising Goal by $105M

UP NEXT

Trump Threatens Musk’s Government Deals as Feud Explodes Over Tax-Cut Bill

UP NEXT

Trump Amplifies Outlandish Robot Biden Conspiracy Theory

UP NEXT

American Doctors Are Moving to Canada To Escape the Trump Administration

UP NEXT

Loretta Swit, Emmy-winner Who Played Houlihan on Pioneering TV Series ‘M.A.S.H.,’ Has Died at 87

UP NEXT

1 in 4 US Children Have Parents With Substance Use Disorder, Study Finds

UP NEXT

Dozens Sickened in Expanding Salmonella Outbreak Linked to Recalled Cucumbers

Southern California Air Regulators Weigh a Plan to Phase Out Gas Furnaces and Water Heaters

3 hours ago

US Supreme Court Allows DOGE Broad Access to Social Security Data

3 hours ago

Doctors Were Preparing to Remove Their Organs. Then They Woke Up.

3 hours ago

Abrego Garcia Is Returned to US From El Salvador

3 hours ago

Proud Boys Convicted in Jan. 6 Attack Sue Government on Claims of ‘Political Persecution’

4 hours ago

FDA’s AI Assistant ‘Elsa’ Fails Its First Day on the Job

4 hours ago

Documentary Series Goes Inside Trump’s Bubble

4 hours ago

Tulare County Gang Member Convicted of Trying to a Murder Police Officer

4 hours ago

Newsom Promises Funding to Jump-Start ‘Science of Reading’

5 hours ago

Feds Indict SoCal Hospice CEO for Medicare Fraud in Fresno and Kern Counties

5 hours ago

World’s Largest Almond Processor Will Shutter Sacramento Plant. 600 Workers Impacted

The world’s largest almond processor, Blue Diamond Growers, says it will close its Sacramento processing plant this year The almond co...

1 hour ago

1 hour ago

World’s Largest Almond Processor Will Shutter Sacramento Plant. 600 Workers Impacted

3 hours ago

Trump Eyes Major Funding Cuts for California, Including All Public Universities

3 hours ago

Farming Regulation Costs Rise 1,300% Since 2006: Cal Poly

4 hours ago

Southern California Air Regulators Weigh a Plan to Phase Out Gas Furnaces and Water Heaters

4 hours ago

US Supreme Court Allows DOGE Broad Access to Social Security Data

4 hours ago

Doctors Were Preparing to Remove Their Organs. Then They Woke Up.

4 hours ago

Abrego Garcia Is Returned to US From El Salvador

5 hours ago

Proud Boys Convicted in Jan. 6 Attack Sue Government on Claims of ‘Political Persecution’

Help continue the work that gets you the news that matters most.

Search

Send this to a friend